No headlines found.
InvestorBrandMedia (Thu, 21-Mar 7:20 PM ET)
PRNewswire (Thu, 14-Mar 8:45 AM ET)
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
PRNewswire (Mon, 11-Mar 8:00 AM ET)
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
PRNewswire (Mon, 12-Feb 7:30 AM ET)
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
PRNewswire (Mon, 29-Jan 8:50 AM ET)
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
PRNewswire (Tue, 23-Jan 7:55 AM ET)
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
PRNewswire (Wed, 10-Jan 9:00 AM ET)
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Anixa Biosciences trades on the NASDAQ stock market under the symbol ANIX.
As of March 28, 2024, ANIX stock price declined to $3.12 with 123,328 million shares trading.
ANIX has a beta of 0.93, meaning it tends to be less sensitive to market movements. ANIX has a correlation of 0.03 to the broad based SPY ETF.
ANIX has a market cap of $99.53 million. This is considered a Micro Cap stock.
In the last 3 years, ANIX stock traded as high as $6.45 and as low as $2.30.
The top ETF exchange traded funds that ANIX belongs to (by Net Assets): VTI, VXF, IWC, DFAC.
ANIX has underperformed the market in the last year with a price return of -32.6% while the SPY ETF gained +33.6%. ANIX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.8% and -1.9%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
ANIX support price is $3.04 and resistance is $3.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIX stock will trade within this expected range on the day.